Consequences of genomic diversity in mycobacterium tuberculosis

Seminars in Immunology

Volumn 26, Issue 6, 2014, Pages 431-444

  Coscolla, Mireia ^a,b   Gagneux, Sebastien ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Diversity; Genome; Lineage; SNP; Transmission; Virulence

Indexed keywords

BACTERIAL VIRULENCE; CHINA; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EUROPEAN AMERICAN; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PHYLOGENY; REVIEW; CLASSIFICATION; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; LUNG TUBERCULOSIS; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYLOGEOGRAPHY; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSMISSION; VIRULENCE;

GENETIC VARIATION; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PHYLOGENY; PHYLOGEOGRAPHY; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 84920035668     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.09.012     Document Type: Review

References (232)

1. O'Garra A., Redford P.S., McNab F.W., Bloom C.I., Wilkinson R.J., Berry M.P.R. The immune response in tuberculosis. Annu Rev Immunol 2013, 31:475-527.
2. Comas I., Gagneux S. The past and future of tuberculosis research. PLoS Pathog 2009, 5.
3. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002, 20:581-620.
4. Clark M., Riben P., Nowgesic E. The association of housing density, isolation and tuberculosis in Canadian First Nations communities. Int J Epidemiol 2002, 31:940-945.
5. Lygizos M., Shenoi S., Brooks R., Bhushan A., Brust J., Zelterman D., et al. Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa. BMC Infect Dis 2013, 13:300.
6. Comas I., Gagneux S. A role for systems epidemiology in tuberculosis research. Trends Microbiol 2011, 19:492-500.
7. Coscollá M., Gagneux S. Does M. tuberculosis genomic diversity explain disease diversity?. Drug Discov Today: Dis Mech 2010, 7:e43-e59.
8. Parwati I., van Crevel R., van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 2010, 10:103-111.
9. Gagneux S. Genetic diversity in Mycobacterium tuberculosis. Curr Top Microbiol Immunol 2013, 374:1-25.
10. Comas I., Homolka S., Niemann S., Gagneux S. Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS ONE 2009, 4:e7815.
11. Stucki D., Gagneux S. Single nucleotide polymorphisms in Mycobacterium tuberculosis and the need for a curated database. Tuberculosis 2013, 93:30-39.
12. Jagielski T., van Ingen J., Rastogi N., Dziadek J., Mazur P.K., Bielecki J. Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int 2014.
13. Ogura Y., Ooka T., Iguchi A., Toh H., Asadulghani M., Oshima K., et al. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci USA 2009, 106:17939-17944.
14. Chewapreecha C., Marttinen P., Croucher N.J., Salter S.J., Harris S.R., Mather A.E., et al. Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genes. PLoS Genet 2014, 10:e1004547.
15. van Embden J.D., Cave M.D., Crawford J.T., Dale J.W., Eisenach K.D., Gicquel B., et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993, 31:406-409.
16. Small P.M., Hopewell P.C., Singh S.P., Paz A., Parsonnet J., Ruston D.C., et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994, 1703-1709.
17. Alland D., Kalkut G.E., Moss A.R., McAdam R.A., Hahn J.A., Bosworth W., et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994, 1710-1716.
18. Demay C., Liens B., Burguiere T., Hill V., Couvin D., Millet J., et al. SITVITWEB - a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol 2012, 12:755-766.
19. Weniger T., Krawczyk J., Supply P., Niemann S., Harmsen D. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res 2010, 38:W326-W331.
20. Hirsh A.E., Tsolaki A.G., DeRiemer K., Feldman M.W., Small P.M. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci USA 2004, 101:4871-4876.
21. Mostowy S., Onipede A., Gagneux S., Niemann S., Kremer K., Desmond E.P., et al. Genomic analysis distinguishes Mycobacterium africanum. J Clin Microbiol 2004, 42:3594-3599.
22. Mostowy S., Cousins D., Behr M.A. Genomic interrogation of the dassie bacillus reveals it as a unique RD1 mutant within the Mycobacterium tuberculosis complex. J Bacteriol 2004, 186:104-109.
23. Tsolaki A.G., Hirsh A.E., DeRiemer K., Enciso J.A., Wong M.Z., Hannan M., et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc Natl Acad Sci USA 2004, 101:4865-4870.
24. Gagneux S., DeRiemer K., Van T., Kato-Maeda M., de Jong B.C., Narayanan S., et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006, 103:2869-2873.
25. Tsolaki A.G., Gagneux S., Pym A.S., Goguet De la Salmoniere Y.-O., Kreiswirth B.N., Van Soolingen D., et al. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 2005, 43:3185-3191.
26. Alland D., Lacher D.W., Hazbon M.H., Motiwala A.S., Qi W., Fleischmann R.D., et al. Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysis. J Clin Microbiol 2007, 45:39-46.
27. Namouchi A., Didelot X., Schock U., Gicquel B., Rocha E.P.C. After the bottleneck: genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection. Genome Res 2012, 22:721-734.
28. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393:537-544.
29. Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O., Peterson J., et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol 2002, 184:5479-5490.
30. Garnier T., Eiglmeier K., Camus J.C., Medina N., Mansoor H., Pryor M., et al. The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 2003, 100:7877-7882.
31. Gutacker M.M., Smoot J.C., Migliaccio C.A.L., Ricklefs S.M., Hua S., Cousins D.V., et al. Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 2002, 162:1533-1543.
32. Gutacker M.M., Mathema B., Soini H., Shashkina E., Kreiswirth B.N., Graviss E.A., et al. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis 2006, 121-128.
33. Filliol I., Motiwala A.S., Cavatore M., Qi W., Hernando Hazbon M., Bobadilla Del Valle M., et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 2006, 188:759-772.
34. Baker L., Brown T., Maiden M.C., Drobniewski F. Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg Infect Dis 2004, 1568-1577.
35. Hershberg R., Lipatov M., Small P.M., Sheffer H., Niemann S., Homolka S., et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 2008, 6:e311.
36. Dos Vultos T., Mestre O., Rauzier J., Golec M., Rastogi N., Rasolofo V., et al. Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis. PLoS ONE 2008, 3:e1538.
37. Homolka S., Projahn M., Feuerriegel S., Ubben T., Diel R., Nubel U., et al. High resolution discrimination of clinical Mycobacterium tuberculosis complex strains based on single nucleotide polymorphisms. PLoS ONE 2012, 7.
38. Stucki D., Malla B., Hostettler S., Huna T., Feldmann J., Yeboah-Manu D., et al. Two new rapid SNP-typing methods for classifying Mycobacterium tuberculosis complex into the main phylogenetic lineages. PLoS ONE 2012, 7.
39. Bergval I., Sengstake S., Brankova N., Levterova V., Abadia E., Tadumaze N., et al. Combined species identification, genotyping, and drug resistance detection of Mycobacterium tuberculosis Cultures by MLPA on a bead-based array. PLoS ONE 2012, 7:e43240.
40. Sengstake S., Bablishvili N., Schuitema A., Bzekalava N., Abadia E., de Beer J., et al. Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates. BMC Genom 2014, 15:572.
41. Cowan L.S., Diem L., Brake M.C., Crawford J.T. Transfer of a Mycobacterium tuberculosis genotyping method, spoligotyping, from a reverse line-blot hybridization, membrane-based assay to the Luminex multianalyte profiling system. J Clin Microbiol 2004, 42:474-477.
42. Abadia E., Zhang J., Ritacco V., Kremer K., Ruimy R., Rigouts L., et al. The use of microbead-based spoligotyping for Mycobacterium tuberculosis complex to evaluate the quality of the conventional method: providing guidelines for quality assurance when working on membranes. BMC Infect Dis 2011, 11.
43. Gomgnimbou M.K., Hernandez-Neuta I., Panaiotov S., Bachiyska E., Palomino J.C., Martin A., et al. Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices. J Clin Microbiol 2013, 51:3527-3534.
44. Casali N., Nikolayevskyy V., Balabanova Y., Ignatyeva O., Kontsevaya I., Harris S.R., et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res 2012, 22:735-745.
45. Casali N., Nikolayevskyy V., Balabanova Y., Harris S.R., Ignatyeva O., Kontsevaya I., et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 2014, 46:279-286.
46. Roetzer A., Schuback S., Diel R., Gasau F., Ubben T., di Nauta A., et al. Evaluation of Mycobacterium tuberculosis typing methods in a four-year study in Schleswig-Holstein, Northern Germany. J Clin Microbiol 2011, 4173-4178.
47. Gardy J.L., Johnston J.C., Sui S.J.H., Cook V.J., Shah L.N., Brodkin E., et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 2011, 364:730-739.
48. Walker T.M., Clp C.L., Harrell R.H., Evans J.T., Kapatai G., Dedicoat M.J., et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013, 13:137-146.
49. Merker M., Kohl T.A., Roetzer A., Truebe L., Richter E., Rüsch-Gerdes S., et al. Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS ONE 2013, 8:e82551.
50. Perez-Lago L., Comas I., Navarro Y., Gonzalez-Candelas F., Herranz M., Bouza E., et al. Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. J Infect Dis 2014, 209:98-108.
51. Ioerger T.R., Feng Y., Ganesula K., Chen X., Dobos K.M., Fortune S., et al. Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. J Bacteriol 2010, 192:3645-3653.
52. Comas I., Borrell S., Roetzer A., Rose G., Malla B., Kato-Maeda M., et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 2012, 44:106-110.
53. Pan Y., Yang X., Duan J., Lu N., Leung A.S., Tran V., et al. The whole genome sequence of four BCG vaccine strains. J Bacteriol 2011, 3152-3153.
54. Copin R., Coscolla M., Efstathiadis E., Gagneux G., Ernst J.D. Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG). Vaccine 2014, 32:5998-6004.
55. Lew J.M., Kapopoulou A., Jones L.M., Cole S.T. TubercuList - 10 years after. Tuberculosis 2011, 91:1-7.
56. Coll F., Mallard K., Preston M.D., Bentley S., Parkhill J., McNerney R., et al. SpolPred: rapid and accurate prediction of Mycobacterium tuberculosis spoligotypes from short genomic sequences. Bioinformatics 2012, 28:2991-2993.
57. Steiner A., Stucki D., Coscolla M., Borrell S., Gagneux S., Kvar Q. Targeted and direct variant calling from FastQ reads of bacterial genomes. BMC Genom 2014, 15:881.
58. Smith N.H., Kremer K., Inwald J., Dale J., Driscoll J.R., Gordon S.V., et al. Ecotypes of the Mycobacterium tuberculosis complex. J Theor Biol 2006, 239:220-225.
59. Cousins D.V., Peet R.L., Gaynor W.T., Williams S.N., Gow B.L. Tuberculosis in imported hyrax (Procavia capensis) caused by an unusual variant belonging to the Mycobacterium tuberculosis complex. Vet Microbiol 1994, 42:135-145.
60. Alexander K.A., Laver P.N., Michel A.L., Williams M., van Helden P.D., Warren R.M., et al. Novel Mycobacterium tuberculosis complex pathogen, M. mungi. Emerg Infect Dis 2010, 1296-1299.
61. Coscolla M., Lewin A., Metzger S., Maetz-Rennsing K., Calvignac-Spencer S., Nitsche A., et al. Novel Mycobacterium tuberculosis complex isolate from a wild chimpanzee. Emerg Infect Dis 2013, 19:969-976.
62. Parsons S.D.C., Drewe J.A., van Pittius N.C.G., Warren R.M., van Heiden P.D. Novel cause of tuberculosis in Meerkats, South Africa. Emerg Infect Dis 2013, 19:2004-2007.
63. Canetti G. Infection caused by atypical mycobacteria and antituberculous immunity. Lille Med 1970, 15:280-282.
64. van Soolingen D., Hoogenboezem T., de Haas P.E.W., Hermans P.W.M., Koedam M.A., Teppema K.S., et al. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 1997, 47:1236-1245.
65. Supply P., Marceau M., Mangenot S., Roche D., Rouanet C., Khanna V., et al. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet 2013, 45:172-179.
66. Gutierrez M.C., Brisse S., Brosch R., Fabre M., Omaïs B., Marmiesse M., et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 2005, 1:e5.
67. Blouin Y., Cazajous G., Dehan C., Soler C., Vong R., Hassan M.O., et al. Progenitor "Mycobacterium canettii" clone responsible for lymph node tuberculosis epidemic, Djibouti. Emerg Infect Dis 2014, 20:21-28.
68. Brosch R., Gordon S.V., Marmiesse M., Brodin P., Buchrieser C., Eiglmeier K., et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 2002, 99:3684-3689.
69. Wirth T., Hildebrand F., Allix-Beguec C., Wölbeling F., Kubica T., Kremer K., et al. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog 2008, 4:e1000160.
70. Reed M.B., Pichler V.K., McIntosh F., Mattia A., Fallow A., Masala S., et al. Major Mycobacterium tuberculosis lineages associate with patient country of origin. J Clin Microbiol 2009, 47:1119-1128.
71. de Jong B.C., Antonio M., Gagneux S. Mycobacterium africanum - review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis 2010, 4.
72. Gehre F., Antonio M., Fahun F., Odoun M., Uwizeye C., de Rijk P., et al. The first phylogeographic population structure and analysis of transmission dynamics of M. africanum West African combining molecular data from Benin, Nigeria and Sierra Leone. PLoS ONE 2013, 8:e77000.
73. Blouin Y., Hauck Y., Soler C., Fabre M., Vong R., Dehan C., et al. Significance of the identification in the horn of Africa of an exceptionally deep branching Mycobacterium tuberculosis clade. PLoS ONE 2012, 7.
74. Firdessa R., Berg S., Hailu E., Schelling E., Gumi B., Erenso G., et al. Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia. Emerg Infect Dis 2013, 19:460-463.
75. Bos K.I., Harkins K.M., Herbig A., Coscolla M., Weber N., Comas I., et al. Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis. Nature 2014, [Epub ahead of print].
76. Comas I., Coscolla M., Luo T., Borrell S., Holt K.E., Kato-Maeda M., et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 2013, 45:1176-1182.
77. Comas I., Chakravartti J., Small P.M., Galagan J., Niemann S., Kremer K., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010, 42:498-503.
78. Rose G., Cortes T., Comas I., Coscolla M., Gagneux S., Young D.B. Mapping of genotype-phenotype diversity among clinical isolates of Mycobacterium tuberculosis by sequence-based transcriptional profiling. Genome Biol Evol 2013, 5:1849-1862.
79. Achtman M. Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu Rev Microbiol 2008, 62:53-70.
80. Shih C.H., Chang C.M., Lin Y.S., Lo W.C., Hwang J.K. Evolutionary information hidden in a single protein structure. Proteins 2012, 80:1647-1657.
81. Farhat M.R., Shapiro B.J., Kieser K.J., Sultana R., Jacobson K.R., Victor T.C., et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet 2013, 45:1183-1189.
82. Zhang H.T., Li D.F., Zhao L.L., Fleming J., Lin N., Wang T., et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 2013, 45:1255-1260.
83. Osorio N.S., Rodrigues F., Gagneux S., Pedrosa J., Pinto-Carbo M., Castro A.G., et al. Evidence for diversifying selection in a set of Mycobacterium tuberculosis genes in response to antibiotic- and nonantibiotic-related pressure. Mol Biol Evol 2013, 30:1326-1336.
84. Lipsitch M., O'Hagan J. Patterns of antigenic diversity and the mechanisms that maintain them. J R Soc Interface 2007, 4:787-802.
85. Rodrigo T., Cayla J.A., de Olalla P.G., Galdos Tanguis H., Jansa J.M., Miranda P., et al. Characteristics of tuberculosis patients who generate secondary cases. Int J Tuberc Lung Dis 1997, 1:352-357.
86. Gehre F., Otu J., De Riemer K., de Sessions P.F., Hibberd M.L., Mulders W., et al. Deciphering the growth behaviour of Mycobacterium africanum. PLoS Negl Trop Dis 2013, 7:e2220.
87. Sarkar R., Lenders L., Wilkinson K.A., Wilkinson R.J., Nicol M.P. Modern lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocyte-derived macrophages. PLoS ONE 2012, 7:e43170.
88. Homolka S., Niemann S., Russell D.G., Rohde K.H. Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog 2010, 6:e1000988.
89. Krishnan N., Malaga W., Constant P., Caws M., Thi Hoang Chau T., Salmons J., et al. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS ONE 2011, 6:e23870.
90. Khatri B., Fielder M., Jones G., Newell W., Abu-Oun M., Wheeler P.R. High throughput phenotypic analysis of Mycobacterium tuberculosis and Mycobacterium bovis strains' metabolism using biolog phenotype microarrays. PLoS ONE 2013, 8:e52673.
91. Portevin D., Sukumar S., Coscolla M., Shui G., Li B., Guan X.L., et al. Lipidomics and genomics of Mycobacterium tuberculosis reveal lineage-specific trends in mycolic acid biosynthesis. Microbiol Open 2014.
92. Vander Beken S., Al Dulayymi J.R., Naessens T., Koza G., Maza-Iglesias M., Rowles R., et al. Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur J Immunol 2011, 41:450-460.
93. Yuan Y., Lee R.E., Besra G.S., Belisle J.T., Barry C.E. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995, 92:6630-6634.
94. Muller B., Borrell S., Rose G., Gagneux S. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet 2013, 29:160-169.
95. Trauner A., Borrell S., Reither K., Gagneux S. Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy. Drugs 2014, 1063-1072.
96. Ryndak M., Wang S., Smith I. PhoP, a key player in Mycobacterium tuberculosis virulence. Trends Microbiol 2008, 16:528-534.
97. Chesne-Seck M.L., Barilone N., Boudou F., Asensio J.G., Kolattukudy P.E., Martin C., et al. A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra. J Bacteriol 2008, 190:1329-1334.
98. Gonzalo-Asensio J.s., Malaga W., Pawlik A., Astarie-Dequeker C., Passemar C., Moreau F., et al. Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator. Proc Natl Acad Sci USA 2014.
99. Shell S.S., Prestwich E.G., Baek S.H., Shah R.R., Sassetti C.M., Dedon P.C., et al. DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis. PLoS Pathog 2013, 9:e1003419.
100. Ando H., Miyoshi-Akiyama T., Watanabe S., Kirikae T. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis. Mol Microbiol 2014, 91:538-547.
101. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um K.S., Wilson T., et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994, 263:227-230.
102. Guo H., Seet Q., Denkin S., Parsons L., Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol 2006, 55:1527-1531.
103. Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., Wheeler P.R., et al. Massive gene decay in the leprosy bacillus. Nature 2001, 409:1007-1011.
104. Bentley S.D., Comas I., Bryant J.M., Walker D., Smith N.H., Harris S.R., et al. The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex. PLoS Negl Trop Dis 2012, 6:e1552.
105. Wagner A. Gene duplications, robustness and evolutionary innovations. Bioessays 2008, 30:367-373.
106. Gey Van Pittius N., Sampson S., Lee H., Kim Y., Van Helden P., Warren R. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol 2006, 6:95.
107. Chaitra M.G., Hariharaputran S., Chandra N.R., Shaila M.S., Nayak R. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential. Vaccine 2005, 23:1265-1272.
108. Chaitra M.G., Nayak R., Shaila M.S. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Vaccine 2007, 25:7168-7176.
109. Chaitra M.G., Shaila M.S., Nayak R. Detection of interferon gamma-secreting CD8+ T lymphocytes in humans specific for three PE/PPE proteins of Mycobacterium tuberculosis. Microbes Infect 2008, 10:858-867.
110. Talarico S., Cave M.D., Marrs C.F., Foxman B., Zhang L., Yang Z. Variation of the Mycobacterium tuberculosis PE_PGRS33 gene among clinical isolates. J Clin Microbiol 2005, 43:4954-4960.
111. Karboul A., Gey van Pittius N., Namouchi A., Vincent V., Sola C., Rastogi N., et al. Insights into the evolutionary history of tubercle bacilli as disclosed by genetic rearrangements within a PE_PGRS duplicated gene pair. BMC Evol Biol 2006, 6:107.
112. Talarico S., Zhang L., Marrs C.F., Foxman B., Cave M.D., Brennan M.J., et al. Mycobacterium tuberculosis PE_PGRS16 and PE_PGRS26 genetic polymorphism among clinical isolates. Tuberculosis 2008, 88:283-294.
113. McEvoy C., van Helden P., Warren R., van Pittius N. Evidence for a rapid rate of molecular evolution at the hypervariable and immunogenic Mycobacterium tuberculosis PPE38 gene region. BMC Evol Biol 2009, 9:237.
114. Copin R., Coscolla M., Seiffert S.N., Bothamley G., Sutherland J., Mbayo G., et al. Sequence diversity in the PE_PGRS genes of Mycobacterium tuberculosis is independent of human T cell recognition. mBio 2014, 5.
115. Dheenadhayalan V., Delogu G., Brennan M.J. Expression of the PE_PGRS 33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival. Microbes Infect 2005.
116. Yu G., Fu X., Jin K., Zhang L., Wu W., Cui Z., et al. Integrative analysis of transcriptome and genome indicates two potential genomic islands are associated with pathogenesis of Mycobacterium tuberculosis. Gene 2011, 489:21-29.
117. Domenech P., Kolly G.S., Leon-Solis L., Fallow A., Reed M.B. Massive gene duplication event among clinical isolates of the Mycobacterium tuberculosis W/Beijing family. J Bacteriol 2010, 192:4562-4570.
118. Weiner B., Gomez J., Victor T.C., Warren R.M., Sloutsky A., Plikaytis B.B., et al. Independent large scale duplications in multiple M. tuberculosis lineages overlapping the same genomic region. PLoS ONE 2012, 7:e26038.
119. Brosch R., Gordon S.V., Buchrieser C., Pym A.S., Garnier T., Cole S.T. Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast 2000, 17:111-123.
120. Brosch R., Gordon S.V., Garnier T., Eiglmeier K., Frigui W., Valenti P., et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 2007, 104:5596-5601.
121. Fenner L., Malla B., Ninet B., Dubuis O., Stucki D., Borrell S., et al. Pseudo-Beijing: evidence for convergent evolution in the direct repeat region of Mycobacterium tuberculosis. PLoS ONE 2011, 6:e24737.
122. Julier C., Hyer R.N., Davies J., Merlin F., Soularue P., Briant L., et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991, 354:155-159.
123. Jordan P., Snyder L., Saunders N. Strain-specific differences in Neisseria gonorrhoeae associated with the phase variable gene repertoire. BMC Microbiol 2005, 5:21.
124. Alamro M., Bidmos F.A., Chan H., Oldfield N.J., Newton E., Bai X., et al. Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage. Infect Immun 2014, 82:2472-2484.
125. Yindeeyoungyeon W., Likitvivatanavong S., Palittapongarnpim P. Characterization of alpha-isopropylmalate synthases containing different copy numbers of tandem repeats in Mycobacterium tuberculosis. BMC Microbiol 2009, 9:122.
126. Olsen I., Balasingham S.V., Davidsen T., Debebe E., Rodland E.A., van Soolingen D., et al. Characterization of the major formamidopyrimidine-DNA glycosylase homolog in Mycobacterium tuberculosis and its linkage to variable tandem repeats. FEMS Immunol Med Microbiol 2009, 56:151-161.
127. Tantivitayakul P., Panapruksachat S., Billamas P., Palittapongarnpim P. Variable number of tandem repeat sequences act as regulatory elements in Mycobacterium tuberculosis. Tuberculosis 2010, 90:311-318.
128. Perez-Lago L., Navarro Y., Herranz M., Bouza E., Garcia-De-Viedma D. Differences in gene expression between clonal variants of Mycobacterium tuberculosis emerging as a result of microevolution. Int J Med Microbiol 2013, 303:674-677.
129. Soto C.Y., Menendez M.C., Perez E., Samper S., Gomez A.B., Garcia M.J., et al. IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks. J Clin Microbiol 2004, 42:212-219.
130. Safi H., Barnes P.F., Lakey D.L., Shams H., Samten B., Vankayalapati R., et al. IS6110 functions as a mobile, monocyte-activated promoter in Mycobacterium tuberculosis. Mol Microbiol 2004, 52:999-1012.
131. Alonso H., Aguilo J.I., Samper S.A., Caminero J.A., Campos-Herrero M.a.I., Gicquel B., et al. Deciphering the role of IS6110 in a highly transmissible Mycobacterium tuberculosis Beijing strain, GC1237. Tuberculosis 2011, 91:117-126.
132. Millan-Lou M.I., Lopez-Calleja A.I., Colmenarejo C., Lezcano M.A., Vitoria M.A., Del Portillo P., et al. Global study of IS6110 in a successful Mycobacterium tuberculosis strain: clues for deciphering its behavior and for its rapid detection. J Clin Microbiol 2013, 51:3631-3637.
133. Mostowy S., Cousins D., Brinkman J., Aranaz A., Behr M. Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis 2002, 186:74-80.
134. Zhang Y., Young D. Strain variation in the katG region of Mycobacterium tuberculosis. Mol Microbiol 1994, 14:301-308.
135. Rouse D.A., Morris S.L. Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infect Immun 1995, 63:1427-1433.
136. Constant P., Perez E., Malaga W., Laneelle M.A., Saurel O., Daffe M., et al. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. J Biol Chem 2002, 277:38148-38158.
137. Sinsimer D., Huet G., Manca C., Tsenova L., Koo M.S., Kurepina N., et al. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun 2008, 76:3027-3036.
138. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431:84-87.
139. Cambier C.J., Takaki K.K., Larson R.P., Hernandez R.E., Tobin D.M., Urdahl K.B., et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 2014, 505:218-222.
140. Newton S.M., Smith R.J., Wilkinson K.A., Nicol M.P., Garton N.J., Staples K.J., et al. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci USA 2006, 103:15594-15598.
141. Kong Y., Cave M.D., Yang D., Zhang L., Marrs C.F., Foxman B., et al. Distribution of insertion- and deletion-associated genetic polymorphisms among four Mycobacterium tuberculosis phospholipase C genes and associations with extrathoracic tuberculosis: a population-based study. J Clin Microbiol 2005, 43:6048-6053.
142. Sharma K., Gupta M., Pathak M., Gupta N., Koul A., Sarangi S., et al. Transcriptional control of the mycobacterial embCAB Operon by PknH through a regulatory protein, EmbR, in vivo. J Bacteriol 2006, 188:2936-2944.
143. Briken V., Porcelli S.A., Besra G.S., Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 2004, 53:391-403.
144. Basu S., Pathak S.K., Banerjee A., Pathak S., Bhattacharyya A., Yang Z., et al. Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-α. J Biol Chem 2007, 282:1039-1050.
145. Talarico S., Donald Cave M., Foxman B., Marrs C.F., Zhang L., Bates J.H., et al. Association of Mycobacterium tuberculosis PE_PGRS33 polymorphism with clinical and epidemiological characteristics. Tuberculosis 2007, 87:338-346.
146. Brites D., Gagneux S. Old and new selective pressures on Mycobacterium tuberculosis. Infect Genet Evol 2012, 12:678-685.
147. Ernst J.D. The immunological life cycle of tuberculosis. Nat Rev Immunol 2012, 12:581-591.
148. Redford P.S., Murray P.J., O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol 2011, 4:261-270.
149. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFNγ. Proc Natl Acad Sci U S A 2001, 98:5752-5757.
150. Li Q., Whalen C.C., Albert J.M., Larkin R., Zukowski L., Cave M.D., et al. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun 2002, 70:6489-6493.
151. Manca C., Reed M.B., Freeman S., Mathema B., Kreiswirth B., Barry C.E., et al. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect Immun 2004, 5511-5514.
152. Manca C., Tsenova L., Freeman S., Barczak A.K., Tovey M., Murray P.J., et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 2005, 694-701.
153. Tsenova L., Ellison E., Harbacheuski R., Moreira A., Kurepina N., Reed M., et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 2005, 192:98-106.
154. Chacón-Salinas R., Serafín-López J., Ramos-Payín R., Méndez-Aragón P., Hernández-Pando R., van Soolingen D., et al. Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2005, 140:443-449.
155. Rocha-Ramirez L.M., Estrada-Garcia I., Lopez-Marin L.M., Segura-Salinas E., Mendez-Aragon P., van Soolingen D., et al. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis 2008, 88:212-220.
156. Subbian S., Bandyopadhyay N., Tsenova L., O'Brien P., Khetani V., Kushner N., et al. Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits. Cell Commun Sign 2013, 11:60.
157. Portevin D., Gagneux S., Comas I., Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog 2011, 7:e1001307.
158. Reiling N., Homolka S., Walter K., Brandenburg J., Niwinski L., Ernst M., et al. Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice. mBio 2013, 4.
159. Chen Y.Y., Chang J.R., Huang W.F., Hsu S.C., Kuo S.C., Sun J.R., et al. The pattern of cytokine production in vitro induced by ancient and modern Beijing Mycobacterium tuberculosis strains. PLoS ONE 2014, 9:e94296.
160. Mihret A., Bekele Y., Loxton A.G., Aseffa A., Howe R., Walzl G. Plasma level of IL-4 differs in patients infected with different modern lineages of M. tuberculosis. J Trop Med 2012, 518564.
161. Tanveer M., Hasan Z., Kanji A., Hussain R., Hasan R. Reduced TNF-[alpha] and IFN-[gamma] responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain. Trans R Soc Trop Med Hyg 2009, 103:581-587.
162. Wang C., Peyron P., Mestre O., Kaplan G., van Soolingen D., Gao Q., et al. Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PLoS ONE 2010, 5:e13594.
163. van Laarhoven A., Mandemakers J.J., Kleinnijenhuis J., Enaimi M., Lachmandas E., Joosten L.A.B., et al. Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype. Infect Immun 2013, 81:3750-3756.
164. Carmona J., Cruz A., Moreira-Teixeira L., Sousa C., Sousa J., Osorio N.S., et al. Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on the immune response. PLoS ONE 2013, 8.
165. Coussens A.K., Wilkinson R.J., Nikolayevskyy V., Elkington P.T., Hanifa Y., Islam K., et al. Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog 2013, 9:e1003468.
166. Stavrum R., PrayGod G., Range N., Faurholt-Jepsen D., Jeremiah K., Faurholt-Jepsen M., et al. Increased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania. BMC Infect Dis 2014, 14:309.
167. de Jong B., Hill P., Aiken A., Awine T., Antonio M., Adetifa I., et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 2008, 198:1037-1043.
168. Via L.E., Weiner D.M., Schimel D., Lin P.L., Dayao E., Tankersley S.L., et al. Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus). Infect Immun 2013, 81:2909-2919.
169. Lan N.T., Lien H.T., Tung L.B., Borgdorff M.W., Kremer K., van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 2003, 1633-1635.
170. Sun Y.J., Lee A.S., Wong S.Y., Paton N.I. Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore. Epidemiol Infect 2006, 329-332.
171. Huyen M.N.T., Buu T.N., Tiemersma E., Lan N.T.N., Dung N.H., Kremer K., et al. Tuberculosis relapse in Vietnam is significantly associated with Mycobacterium tuberculosis Beijing genotype infections. J Infect Dis 2013, 207:1516-1524.
172. Parwati I., Alisjahbana B., Apriani L., Soetikno R., Ottenhoff T., van der Zanden A., et al. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J Infect Dis 2010, 201:553-557.
173. van Crevel R., Nelwan R.H.H., de Lenne W., Veeraragu Y., van der Zanden A.G., Amin Z., et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001, 7:880-883.
174. Ogarkov O., Mokrousov I., Sinkov V., Zhdanova S., Antipina S., Savilov E. Lethal combination of Mycobacterium tuberculosis Beijing genotype and human CD209 -336G allele in Russian male population. Infect Genet Evol 2012, 12:732-736.
175. Nahid P., Bliven E.E., Kim E.Y., Mac Kenzie W.R., Stout J.E., Diem L., et al. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS ONE 2010, 5:e10753.
176. Kato-Maeda M., Shanley C.A., Ackart D., Jarlsberg L.G., Shang S., Obregon-Henao A., et al. Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig. Clin Vaccine Immunol 2012, 19:1227-1237.
177. Aguilar D., Hanekom M., Mata D., van Pittius N.C.G., van Helden P.D., Warren R.M., et al. Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission. Tuberculosis 2010, 90:319-325.
178. Zumla A., Raviglione M., Hafner R., Fordham Von Reyn C. Tuberculosis. N Engl J Med 2013, 368:745-755.
179. Kong Y., Cave M.D., Zhang L., Foxman B., Marrs C.F., Bates J.H., et al. Population-based study of deletions in five different genomic regions of Mycobacterium tuberculosis and possible clinical relevance of the deletions. J Clin Microbiol 2006, 44:3940-3946.
180. Kong Y., Cave M.D., Zhang L., Foxman B., Marrs C.F., Bates J.H., et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of m. tuberculosis clinical isolates. J Clin Microbiol 2007, 45:409-414.
181. Pareek M., Evans J., Innes J., Smith G., Hingley-Wilson S., Lougheed K.E., et al. Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype. Thorax 2013, 68:221-229.
182. Click E.S., Moonan P.K., Winston C.A., Cowan L.S., Oeltmann J.E. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis 2012, 54:211-219.
183. Caws M., Thwaites G., Dunstan S., Hawn T.R., Thi Ngoc Lan N., Thuong N.T.T., et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008, 4:e1000034.
184. Borgdorff M.W., van Deutekom H., de Haas P.E.W.P., Kremer K., van Soolingen D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis 2004, 84:337-340.
185. Nicol M.P., Sola C., February B., Rastogi N., Steyn L., Wilkinson R.J. Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa. J Clin Microbiol 2005, 43:5779-5781.
186. Wampande E., Mupere E., Debanne S., Asiimwe B., Nsereko M., Mayanja H., et al. Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease. BMC Infect Dis 2013, 13:484.
187. van der Spuy G.D., Warren R.M., Richardson M., Beyers N., Behr M.A., van Helden P.D. Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis. J Clin Microbiol 2003, 41:5640-5644.
188. Borgdorff M.W., van Soolingen D. The re-emergence of tuberculosis: what have we learnt from molecular epidemiology. Clin Microbiol Infect 2013, 19:889-901.
189. Buu T.N., van Soolingen D., Huyen M.N.T., Lan N.T.N., Quy H.T., Tiemersma E.W., et al. Increased transmission of Mycobacterium tuberculosis Beijing genotype strains associated with resistance to streptomycin: a population-based study. PLoS ONE 2012, 7:e42323.
190. Yang C., Luo T., Sun G., Qiao K., Sun G., DeRiemer K., et al. Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in china. Clin Infect Dis 2012, 55:1179-1187.
191. Anh D.D., Borgdorff M.W., Van L.N., Lan N.T., van Gorkom T., Kremer K., et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000, 302-305.
192. European Concerted Action on New Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006, 736-743.
193. Hanekom M., van der Spuy G.D., Streicher E., Ndabambi S.L., McEvoy C.R.E., Kidd M., et al. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family was associated with an increased ability to spread and cause disease. J Clin Microbiol 2007, 5:1483-1490.
194. Cowley D., Govender D., February B., Wolfe M., Steyn L., Evans J., et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis 2008, 47:1252-1259.
195. van der Spuy G.D., Kremer K., Ndabambi S.L., Beyers N., Dunbar R., Marais B.J., et al. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis 2009, 89:120-125.
196. Tuite A.R., Guthrie J.L., Alexander D.C., Whelan M.S., Lee B., Lam K., et al. Epidemiological evaluation of spatiotemporal and genotypic clustering of Mycobacterium tuberculosis in Ontario, Canada. Int J Tuberc Lung Dis 2013, 1322-1327.
197. Kubica T., Rusch-Gerdes S., Niemann S. The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany. Int J Tuberc Lung Dis 2004, 8:1107-1113.
198. Lillebaek T., Andersen A.B., Dirksen A., Glynn J.R., Kremer K. Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis 2003, 9:1553-1557.
199. Albanna A.S., Reed M.B., Kotar K.V., Fallow A., McIntosh F.A., Behr M.A., et al. Reduced transmissibility of East African Indian strains of Mycobacterium tuberculosis. PLoS ONE 2011, e25075.
200. Marais B.J., Hesseling A.C., Schaaf H.S., Gie R.P., van Helden P.D., Warren R.M. Mycobacterium tuberculosis transmission is not related to household genotype in a setting of high endemicity. J Clin Microbiol 2009, 47:1338-1343.
201. Langlois-Klassen D., Senthilselvan A., Chui L., Kunimoto D., Saunders L.D., Menzies D., et al. Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991-2007. Emerg Infect Dis 2013, 19:701-711.
202. Kato-Maeda M., Kim E.Y., Flores L., Jarlsberg L.G., Osmond D., Hopewell P.C. Differences among sublineages of the East-Asian lineage of Mycobacterium tuberculosis in genotypic clustering. Int J Tuberc Lung Dis 2010, 538-544.
203. Anderson J., Jarlsberg L.G., Grindsdale J., Osmond D., Kawamura M., Hopewell P.C., et al. Sublineages of Lineage 4 (Euro-American) Mycobacterium tuberculosis differ in genotypic clustering. Int J Tuberc Lung Dis 2013, 885-891.
204. Niobe-Eyangoh S.N., Kuaban C., Sorlin P., Cunin P., Thonnon J., Sola C., et al. Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J Clin Microbiol 2003, 41:2547-2553.
205. Godreuil S., Torrea G., Terru D., Chevenet F., Diagbouga S., Supply P., et al. First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso. J Clin Microbiol 2007, 45:921-927.
206. Groenheit R., Ghebremichael S., Svensson J., Rabna P., Colombatti R., Riccardi F., et al. The Guinea-Bissau family of Mycobacterium tuberculosis complex revisited. PLoS ONE 2011, 6:e18601.
207. Hanekom M., van Pittius N.C.G., McEvoy C., Victor T.C., van Helden P.D., Warren R.M. Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis 2011, 91:510-523.
208. Borrell S., Gagneux S. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis [State of the art]. Int J Tuberc Lung Dis 2009, 13:1456-1466.
209. Lopez B., Aguilar D., Orozco H., Burguer M., Espitia C., Ritacco V., et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003, 133:30-37.
210. Abebe F., Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link?. Clin Exp Immunol 2006, 145:389-397.
211. Tsenova L., Harbacheuski R., Sung N., Ellison E., Fallows D., Kaplan G. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 2007, 25:5126-5132.
212. Gagneux S. Host-pathogen coevolution in human tuberculosis. Philos Trans R Soc B: Biol Sci 2012, 367:850-859.
213. Brudey K., Driscoll J., Rigouts L., Prodinger W., Gori A., Al Hajoj S., et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006, 6:23.
214. Fenner L., Egger M., Bodmer T., Furrer H., Ballif M., Battegay M., et al. HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genet 2013, 9:e1003318.
215. Herb F., Thye T., Niemann S., Browne E.N.L., Chinbuah M.A., Gyapong J., et al. ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet 2008, 17:1052-1060.
216. van Crevel R., Parwati I., Sahiratmadja E., Marzuki S., Ottenhoff T., Netea M., et al. Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. J Infect Dis 2009, 200:1671-1674.
217. Intemann C.D., Thye T., Niemann S., Browne E.N.L., Amanua Chinbuah M., Enimil A., et al. Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog 2009, 5:e1000577.
218. Bartha I.C. A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. eLife Sci 2013, 2.
219. Kodaman N., Sobota R., Mera R., Schneider B.G., Williams S.M. Disrupted human-pathogen co-evolution: a model for disease. Front Genet 2014, 5.
220. Reed L.K., Lee K., Zhang Z., Rashid L., Poe A., Hsieh B., et al. Systems genomics of metabolic phenotypes in wild-type Drosophila melanogaster. Genetics 2014.
221. Kwan C.K., Ernst J.D. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011, 24:351-376.
222. Caws M., Thwaites G., Stepniewska K., Lan N.T.N., Duyen N.T.H., Phuong N.T., et al. Beijing genotype of Mycobacterium tuberculosis significantly associated with HIV and multi-drug resistance in tuberculous meningitis. J Clin Microbiol 2006, JCM-.
223. Middelkoop K., Bekker L., Mathema B., Shashkina E., Kurepina N., Whitelaw A., et al. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J Infect Dis 2009, 200:1207-1211.
224. Viegas S.O., Machado A., Groenheit R., Ghebremichael S., Pennhag A., Gudo P.S., et al. Mycobacterium tuberculosis Beijing genotype is associated with HIV infection in Mozambique. PLoS ONE 2013, 8:e71999.
225. de Jong B.C., Adetifa I., Walther B., Hill P.C., Antonio M., Ota M., et al. Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update. FEMS Immunol Med Microbiol 2010, 58:102-105.
226. Young D., Stark J., Kirschner D. Systems biology of persistent infection: tuberculosis as a case study. Nat Rev Microbiol 2008, 6:520-528.
227. Rose G. A genomic and transcriptomic study of lineage-specific variation in Mycobacterium tuberculosis 2013.
228. Galagan J.E., Sisk P., Stolte C., Weiner B., Koehrsen M., Wymore F., et al. TB database 2010: overview and update. Tuberculosis 2010, 90:225-235.
229. Wattam A.R., Abraham D., Dalay O., Disz T.L., Driscoll T., Gabbard J.L., et al. PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res 2014, 42:D581-D591.
230. Coll F., Preston M., Guerra-Assunao J.A., Hill-Cawthorn G., Harris D., Perdigao J., et al. PolyTB: a genomic variation map for Mycobacterium tuberculosis. Tuberculosis 2014, 94:346-354.
231. Chernyaeva E., Shulgina M., Rotkevich M., Dobrynin P., Simonov S., Shitikov E., et al. Genome-wide Mycobacterium tuberculosis variation (GMTV) database: a new tool for integrating sequence variations and epidemiology. BMC Genom 2014, 15:308.
232. Kohl T.A., Diel R., Harmsen D., Rothgänger J., Meywald Walter K., Merker M., et al. Whole genome based Mycobacterium tuberculosis surveillance: a standardized, portable and expandable approach. J Clin Microbiol 2014.